BioSpace News Archive

Pharm Country

UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option

Jefferies LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Oppenheimer & Co. Inc. acted as lead manager for the offering.

January 24, 2018
·
3 min read
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

The aggregate gross proceeds from the offering are approximately $40.4 million, before deducting the underwriting discounts and commissions and offering expenses.

January 24, 2018
·
2 min read
Biotech Bay

Five Prime Announces Proposed Public Offering of Common Stock

Five Prime intends to grant the underwriters in the offering a 30-day option to purchase up to an additional 15% of these shares of common stock offered in the public offering.

January 24, 2018
·
4 min read
Drug Development

Glenmark Pharma Presents Preliminary Biomarker Data on GBR 1302, a HER2xCD3 Bispecific Monoclonal Antibody, at the ASCO-SITC Clinical Immuno-Oncology Symposium

Glenmark Pharma today announced a presentation of preliminary biomarker findings from a Phase 1 study of GBR 1302.

January 24, 2018
·
3 min read
Business

Gastroenterology Associates, PC, Offers Patients Access to Clinical Research

By offering clinical trials as an option, the physicians at Gastroenterology Associates are able to introduce the latest advances in research to their patients.

January 24, 2018
·
1 min read
Business

Ablynx Appoints Dr. Robert Friesen as CSO

Dr Friesen has more than 20 years of experience in the biopharmaceutical industry, leading multiple Research and Development (R&D) organisations.

January 24, 2018
·
3 min read
Business

Advicenne Appoints Linda Law, MD as U.S. VP, Clinical Development

Dr. Law will oversee Advicenne’s clinical development and medical affairs efforts in North America which are focused on the Company’s most advanced program, ADV7103.

January 24, 2018
·
2 min read
Publishing of Orion Corporation’s Financial Statement Release for 2017 on 7 February 2018

The release and related presentation material in Finnish and in English will be available on the Group’s homepage at www.orion.fi/investors promptly after the publishing.

January 24, 2018
·
1 min read
Pharm Country

Insmed Announces Pricing of Public Offering of Convertible Senior Notes

Insmed has granted the underwriters a 30-day option to purchase up to an additional $50 million in aggregate principal amount of the notes, solely to cover over-allotments.

January 24, 2018
·
10 min read
Biotech Bay

Ultragenyx Announces Pricing of Public Offering of Common Stock

The offering is expected to close on or about January 26, 2018, subject to satisfaction of customary closing conditions.

January 24, 2018
·
4 min read